Effect of prior immunotherapy on the efficacy of chemotherapy in advanced non‐small cell lung cancer: A retrospective study-Reference-Cited by-同舟云学术

Effect of prior immunotherapy on the efficacy of chemotherapy in advanced non‐small cell lung cancer: A retrospective study

Published:2022-04-17 Issue:9 Volume:13 Page:1391-1400
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thoracic Cancer

Author:

Heraudet Luc¹²,Delon Tara²³^ORCID,Veillon Rémi³,Vergnenègre Charlotte³,Lepetit Hélène⁴,Daste Amaury¹,Ravaud Alain¹²,Zysman Maéva²³⁵,Domblides Charlotte¹²⁶

Affiliation:

1. Department of Medical Oncology, Hôpital Saint‐André Bordeaux University Hospital Bordeaux France

2. Faculty of Medicine University of Bordeaux Bordeaux France

3. Pulmonary Department, Pôle Cardio‐thoracique, Hôpital Haut‐Lévèque Bordeaux University Hospital Bordeaux France

4. Unité de soutien méthodologique à la recherche clinique et épidémiologique Bordeaux University Hospital Bordeaux France

5. Centre de Recherche Cardio‐Thoracique de Bordeaux (CRCTB), INSERM U1045 Bordeaux France

6. CNRS UMR5164, ImmunoConcEpT Site de Carreire, University of Bordeaux Bordeaux France

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.14403

Reference26 articles.

1. Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater

2. Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents

3. Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non–Small-Cell Lung Cancer

4. Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors

5. Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancer

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Second-line treatment outcomes after first-line chemotherapy plus immunotherapy in Extensive-Stage small cell lung cancer (ES-SCLC) patients: A large French multicenter study;Lung Cancer;2024-08

2. Salvage lung resection after immunotherapy is feasible and safe;JTCVS Open;2024-08

3. Safety and efficacy of immune checkpoint inhibitor rechallenge in advanced non-small cell lung cancer: a retrospective study;Scientific Reports;2024-01-28

4. Sequential Treatment of Anti-Pd-L1 Therapy Prior to Anti-Vegfr2 Therapy Contributes to More Significant Clinical Benefits in Non-Small Cell Lung Cancer;2024

5. Clinical and Biological Differences between Upper Tract Carcinoma and Bladder Urothelial Cancer, Including Implications for Clinical Practice;Cancers;2023-11-23